Connection

Paola Rogliani to Cystic Fibrosis

This is a "connection" page, showing publications Paola Rogliani has written about Cystic Fibrosis.
Connection Strength

0.047
  1. Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD. Expert Opin Investig Drugs. 2019 Oct; 28(10):827-833.
    View in: PubMed
    Score: 0.024
  2. Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents. Expert Opin Pharmacother. 2018 Dec; 19(18):2043-2053.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.